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ABSTRACT
DNA-damaging agents cause a multifaceted cellular
stress response. Cells set in motion either repair
mechanisms or programmed cell death pathways,
depending on the extent of the damage and on
their ability to withstand it. The RNA-binding
protein (RBP) Sam68, which is up-regulated in
prostate carcinoma, promotes prostate cancer cell
survival to genotoxic stress. Herein, we have
investigated the function of Sam68 in this cellular
response. Mitoxantrone (MTX), a topoisomerase II
inhibitor, induced relocalization of Sam68 from the
nucleoplasm to nuclear granules, together with
several other RBPs involved in alternative splicing,
such as TIA-1, hnRNP A1 and the SR proteins SC35
and ASF/SF2. Sam68 accumulation in nuclear stress
granules was independent of signal transduction
pathways activated by DNA damage. Using BrU
labelling and immunofluorescence, we demonstrate
that MTX-induced nuclear stress granules are
transcriptionally active foci where Sam68 and the
phosphorylated form of RNA polymerase II accu-
mulate. Finally, we show that MTX-induced
relocalization of Sam68 correlates with changes in
alternative splicing of its mRNA target CD44, and
that MTX-induced CD44 splicing depends on
Sam68 expression. These resultsstrongly suggest
that Sam68 is part of a RNA-mediated stress
response of the cell that modulates alternative
splicing in response to DNA damage.
INTRODUCTION
Cells have developed several mechanisms to cope with
external sources of stress, like heat shock and oxidative
stress, or with insults that aﬀect the integrity of the
genome, such as ultraviolet (UV) irradiation and DNA
alkylating agents. Depending on the nature and the per-
sistence of the stress, cells will adopt a ‘safety’ mechanism
to limit and eventually overcome the damage, undergoing
cell cycle arrest and DNA repair, or they will succumb by
activating programmed cell death. A complex and
well-studied stress response is that imposed by DNA
damage (1), which has strong clinical implications in che-
motherapy of human cancers. Most chemotherapeutic
drugs induce breaks in the genome by targeting DNA
processing enzymes, such as the topoisomerase inhibitors,
or DNA directly, such as the alkylating agents. Although
most cells are highly sensitive to these drugs and undergo
apoptosis, cancer cells often escape this response and
adopt mechanisms to withstand and repair the damage,
thereby surviving to treatments. Thus, understanding the
molecular mechanisms that allow cancer cells to survive to
genotoxic stresses is a crucial step in the development of
improved and more eﬃcacious therapies.
Genotoxic stress causes a general suppression of the
transcriptional activity, through degradation of the
RNA polymerase II (RNAPII) (2), which allows to save
energy and readapt the protein repertoire of the cell to the
new tasks. In addition to changes in transcription, recent
evidence demonstrated that genotoxic stress induces large
spectrum modiﬁcations in alternative splicing (AS),
thereby altering the isoforms produced by several genes
(3). AS aﬀects most human genes and allows to expand
the cell proteome through diﬀerential assembly of exons in
the mRNAs. AS is operated by the spliceosome, a
macromolecular machinery composed by small nuclear
ribonucleuprotein particles (snRNPs, U1, U2, U4, U5
and U6) and many constitutive and ancillary proteins
that regulate the assembly of the spliceosome at the
exon-intron junctions (4). The main regulators of consti-
tutive and alternative splicing are RNA-binding proteins
(RBPs) belonging to the serine–arginine (SR) rich
proteins and the heterogeneous ribonucleoproteins
(hnRNPs), which often play antagonistic roles (5).
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reported in cellular responses to many other sources of
stress (6), indicating that it is a crucial regulatory mecha-
nism in cell adaptation to external insults. Moreover,
recent observations have highlighted the speciﬁc diﬀer-
ences in AS regulation in cancer cells (7–10), suggesting
that this step of RNA processing plays a role also in cell
transformation.
In line with its crucial role in the DNA damage
response, several changes in AS of speciﬁc transcripts
have been observed in cancer cells treated with cisplatin
or etoposide. Remarkably, some of these transcripts
encode for proteins regulating apoptosis, such as
Caspase 2 (11) and Bcl-2 related genes (3), cell motility,
like CD44 (12) and cell proliferation, like the p53 negative
modulators MDM2 and MDM4 (13) or cyclin D1b, a
splicing variant aberrantly expressed in prostate and
breast cancer cells that confers resistance to therapies
(14,15). Thus, it is likely that regulation of these AS
events represents a novel mechanism by which cancer
cells gain drug resistance and survive to chemotherapy.
The mechanisms underlying stress-induced changes in
AS are just beginning to be understood (6). A recent
report indicated that UV irradiation alters a substantial
number of splicing events in hepatocarcinoma cells (3).
The AS events were predominantly modulated by
changes in the rate of pre-mRNA transcription,
elicited through phosphorylation of the RNAPII (3).
Nevertheless, additional mechanisms to modulate AS reg-
ulation exist. For instance, in p53-deﬁcient cells, genotoxic
stress caused up-regulation of SRp55, thereby promoting
the inclusions of CD44 variable exons involved in
tumorigenesis (12) and changes in AS of other
cancer-related genes (16). DNA damage and other
stresses can also alter the subcellular distribution of
several RBPs involved in post-transcriptional events.
Cisplatin and a mild heat shock caused accumulation in
the nucleoli of the RNA recognition motif (RRM)-con-
taining protein RDM1, which modulates the cellular
response to genotoxic agents (17). In addition, various
stresses triggered the cytoplasmic translocation of the
splicing regulator hnRNP A1 (18), suggesting that they
might alter nuclear RNA processing events regulated by
this RBP (6). On the other hand, UV irradiation andheat
shock induced accumulation of other RBPs in nuclear
stress bodies (19,20), whose function is still largely
unknown.
An interesting RBP involved in regulation of cell pro-
liferation and survival is Sam68, which belongs to the
signal transduction and activation of RNA (STAR)
family (21). Sam68 is implicated in several steps of pro-
cessing of target genes. In the cytoplasm, it regulates
translation of viral and cellular mRNAs through its asso-
ciation with the polyribosomes or the stress granules
(22–25). In the nucleus, Sam68 integrates signal
transduction pathways with pre-mRNA AS in response
to extracellular cues (26–28). Notably, we have previously
demonstrated that Sam68 is up-regulated in prostate
cancer (PCa) cells, where it sustains their resistance to
treatments with chemotherapeutic agents (29). These
results suggested that Sam68 plays a role in the cellular
response to genotoxic stress. Herein, we have investigated
the function of Sam68 in PCa cells exposed to genotoxic
stress induced by mitoxantrone (MTX), a topoisomerase
II inhibitor used in chemotherapy. Our results demon-
strate that Sam68 takes part to the cellular response to
genotoxic stress by altering its subcellular localization
and contributing to modulation of AS. These results
suggest a novel role for Sam68 in the DNA damage
response of cancer cells.
MATERIALS AND METHODS
Cell culturesand treatments
PC3 and HeLa cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium (Gibco BRL), LNCaP cells were cultured
in RPMI 1640 medium (Lonza), media were supplemented
with 10% fetal bovine serum (FBS) (Lonza), gentamycin,
penicillin and streptomycin. For genotoxic treatments,
cells at 80% of conﬂuence were treated with 80mM
cisplatin (Sigma-Aldrich) for 16h, or with 5mM MTX
(Sigma-Aldrich) for increasing times (2–24h). At the end
of the incubation, cells were ﬁxed and stained for
immunoﬂorescence analysis. For studies involving inhibi-
tors, PC3 cells were pre-incubated for 15min with 10mM
JNK inhibitor 1 (JNK-inh.) (Alexis Biochemicals), 10mM
SB202190 (Calbiochem) for p-38 kinase inhibition or
10mM MNK inhibitor 4-amino-5-(4-ﬂuoroanilino)-
pyrazolo[3,4-d]pyrimidine (MNK-inh.) (Calbiochem), or
1h with 10mM 2-Morpholin-4-yl-6-thianthren-1-yl-
pyran-4-one (ATM-inh.) (Calbiochem), and then
incubated with 5mM MTX for 8–24h. For RNASatIII
induction experiments, PC3 cells were treated either with
heat shock as previously described (30) or with 5mM
MTX (15min to 24h).
Cell proliferation assay, cell viability and cell cycle
analysis
The CellTiter A96 MTS (Promega) assay was used, as
previously described (29), to monitor PC3 cell prolifera-
tion after treatment with MTX (0.5–5mM, Sigma-Aldrich)
for increasing times (24–72h) or for 2h and released for
24–72h after stress. For cell viability analyses, treated PC3
cells were incubated for 5min at room temperature (RT)
with 0.4% Trypan blue solution 1:1 (v/v) (Sigma-Aldrich)
and analysed on a hemocytometer. The percentage of
dead cells (stained) versus viable cells (unstained) was
calculated. Cell cycle analysis with propidium iodide
(10mg/ml) was performed with a FACSCalibur Flow
Cytometer (Becton Dickinson) as described (29).
Stable knockdown of Sam68 in PC3 cells
PC3 cells were transfected either with pLKO.1puro
(control pLKO) or PLKO.1-KHDRBS1_527 (pLKO-
si-Sam68) (MISSION shRNA, Sigma Aldrich) in a 12
multi-well plate using Lipofectamine 2000 reagent
(Invitrogen) according to manufacturer’s instructions.
The puromycin (Sigma-Aldrich) resistance marker was
added at a concentration of 1mg/ml in fresh medium
every 2 days for stable selection and maintenance of
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Plasmid vectors
For the pHsp70.2EGFP-Sam68 expression vector, the
CMV promoter was excised from pEGFPC1-Sam68
(28), substituted with Hsp70.2 promoter, ampliﬁed
withPwo SuperYield DNA polymerase (Roche) from
Hspa2-pblue (generous gift of Prof. E.M. Eddy), and
introduced in pEGFP-C1-Sam68. The cDNA encoding
murine Sam68 was ampliﬁed by PCR using cDNA from
murine embrionalﬁbroblast (MEF) as template and Pfu
polymerase (Roche), cloned in frame with myc into
pCDNA3myc(28). The expression vector pEGFP-GSG
(GFP-Sam68GSG) was previously described (29). All
expression vectors were analysed by sequencing.
Cell transfections and CD44v5-luciferase (v5-Luc)
splicing assay
For GFP-tagged proteins expression, PC3 cells were
seeded the day before transfection (3.5 10
5)i n3 5 m m
plates and then transfected with 1mg of pEGFPhsp70.2-
Sam68 wt or pEGFP-GSG using Lipofectamine 2000
(Invitrogen) according to manufacturer’s instructions.
Twenty-four hours after transfection, cells were treated
with 5mM MTX for 24h, incubated 15min at 37 C with
40,6-diamidino-2-phenylindole (DAPI), washed in
phosphate-buﬀered saline (PBS) and ﬁxed in 4%
paraformaldehyde (PFA) 10min on ice. Cells were then
washed with PBS, mounted with Mowiol (Calbiochem)
and analysed by confocal microscope (28). For
Luciferase assays, control pLKO and pLKO-si-
Sam68PC3 cells were cultured in 12-well plates
( 10 10
5/well). Cells were treated with 5 mM MTX for
2h, rinsed with PBS and let recover with fresh medium
for 2h and then transfected with 0.4mg of minigene
pETv5luc (31), 0.25mg of pCDNA3myc or
pCDNA3mycSam68(mycSam68) and the Renilla
luciferase reporter gene (1ng) as an internal control
using Lipofectamine 2000 (Invitrogen), according to the
manufacturer’s instructions. Twenty-four hours after
transfection, cells wereharvested, lysed and analysed
using a biocounter luminometer using the dual-luciferase
reporter assay system (Promega). Data from three exper-
iments were normalized for transfection eﬃciency using
the ratio between ﬁreﬂy and Renilla luciferase activity.
RNA extraction, real-time PCRand RT–PCR
For endogenous CD44 v5 AS analysis after genotoxic
stress, control pLKO and pLKO-si-Sam68 PC3 stable
clones were treated with 0.5 or 5mM MTX for 2h, let
recover after stress for 24h and then harvested in
TRIzol reagent (Invitrogen) for total RNA extraction
according to the manufacturer’s instructions. After diges-
tion with RNase-free DNase (Roche), 1mg of total RNA
was used for RT using M-MLV reverse transcriptase
(Invitrogen). Quantitative real-time PCRs were carried
outwith Sybr Green mix (for Light-Cycler480 - Roche)
according to manufacturer’s instructions. Primers used
for CD44 v5 were the followings: CD44 v5 Fw 50TGTA
GACAGAAATGGCACCACTG30; CD44 v5 Rev 50TGG
TGCTTGTAGAATGTGGGGTC30. Samples were
normalized on CD44 constitutive isoforms (with respect
to the constitutive exons C6 and C7) using the following
primers: CD44 c Fw 50AGACACATTCCACCCCAG
TG30;CD44 c Rev 50CCAGAGGTTGTGTTTGCTCCA
CC30. The value given for the amount of CD44 v5 PCR
product present in untreated cells was set as 1. Data are
reported as the mean±SD of three independent experi-
ments. For SatIII RNAs expression experiments after heat
shock or MTX treatments, RT–PCRs speciﬁc for G-rich
RNA SatIII were performed as described (30). Samples
were normalized on hypoxantine-phosphoribosyl-
transferase (HPRT) expression levels.
Western blot analysis
Western blot analysis of cell extracts was performed as
previously described (29,32).Protein concentration was
determined by using Bradford reagent (Bio-Rad).
Primary antibodies used (at 1:1000 dilution; overnight
at 4 C): rabbit anti-Sam68, anti-Erk2, anti-TFIIH and
anti-cyclin A, goat anti-lamin b, and mouse anti-cyclin
B1 (Santa Cruz Biotechnology); rabbit p-Chk2 and
p-p38 (Cell Signalling); mouse c-Jun (BD biosciences);
rabbit anti-pJNK1/2 and p-eIF4E (Biosource); mouse
anti-hnRNP A1 (Sigma-Aldrich); rabbit anti-cyclin D1
and anti-Histone 3, unmodiﬁed (Abcam). Secondary
anti-mouse, anti-rabbit or anti-goat IgGs conjugated to
horseradish peroxidase (Amersham) were incubated for
1h at RT (1:10000 dilution in PBS containing 0.1%
Tween-20). Immunostained bands were detected by
chemiluminescent method (Santa Cruz Biotecnology).
Nuclei isolation and chromatin fractionation
PC3 cells were treated with 0.5 or 5mM MTX for 24h.
Nuclei were isolated,resuspended in solution G (300mM
sucrose, 50mM triethanolamine, 25mM KCl, 4mM
MgCl2, 1mM CaCl2 and 1mM phenylmethylsulfonyl
ﬂuoride, pH 7.4) and digested with micrococcal nuclease
(Sigma-Aldrich) at 37 C as previously described (33). For
chromatin fractionation, digested nucleiwere cooled on
ice for 10min and centrifuged at 12800 g for 10min at
4 C. The supernatant (S1) was removed, the pellet was
suspended in 2mM EDTA pH 7.4 and centrifuged to
separate supernatant S2 and pellet (P) as previously
described (34). For protein analysis, samples were
adjusted to 10mM MgCl2 and precipitated with two
volumes of ethanol at  20 C. Protein samples were
analysed by western blot.
Immunoﬂuorescence and bromo-uridine incorporation
Cells were ﬁxed and stained for immunoﬂuorescence
analysis as previously described (28). Primary antibodies
were the followings: rabbit anti-Sam68 1:1000 and goat
anti-TIA-1 1:200 (Santa Cruz, Biotechnology); mouse
anti-gH2AX 1:10000 (Cell signaling); mouse monoclonal
antibody PG-M3 (anti-PML) 1:100 (generous gift from
Prof. F. Lo Coco); mouse anti-hnRNP A1 1:500 and
anti-SC35 1:500 (Sigma-Aldrich); mouse anti-SF2/ASF
1:200 (USBiological) andmouse monoclonal anti-RNA
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DAPI was used for DNA staining and the secondary
antibodies were: Alexa Fluor 488, 568 goat anti-rabbit
and Alexa Fluor 488 goat anti-mouse (1:500)
(Invitrogen); FITC-coniugated donkey anti-rabbit;
cy3-coniugated donkey anti-goat 1:500 andcy3-
coniugated donkey anti-mouse IgM 1:500 (Jackson
Immunoresearch). For BrU incorporation, PC3 cells
were incubated in the last 15min to 1h of culture with
1mM BrU (Sigma-Aldrich). Cells treated with 5mM
MTX (2–24h) were incubated with BrU in the last hour
of treatment. For MTX-release experiments, PC3 cells
were treated with 5mM MTX for 2h and let recover for
24h and incubated with BrU in the last hour of recovery.
Cells were ﬁxed and stained as previously described (35).
Brieﬂy, cells were washed twice with sterile cold PBS sup-
plemented with 1mM MgCl2 and 0.1mM CaCl2(PBS*)
and ﬁxed in PFA 2% for 20min on ice. After
permeabilization with PBS* +0.1% Triton X-100
(PBS*
T) for 5min, samples were quenched with 50mM
NH4Cl in PBS*
T10min, blocked with PBS*
T+1%
BSA for 1h at RT, and incubated with the following
primary antibodies: mouse anti-BrdU (1:40)(Becton-
Dickinson) and rabbit anti-Sam68 (1:500) in
PBS*
T +0.2 % BSA 1h at RT. Cells were washed three
timesinPBS*
T and incubated 1h at RT with the following
secondary antibodies diluted inPBS*
T +0.2 % BSA:
cy3-coniugated donkey anti-mouse 1:100 or cy3-
coniugated donkey anti-mouse 1:100 and FITC donkey
anti-rabbit 1:500 (Jackson Immunoresearch) for
co-stainings. Finally, cells were washed, mounted with
Mowiol (Calbiochem) and analysed by confocal micro-
scope. All the solutions were prepared in RNAase-
freewater. Immunoﬂuorescence analyses were performed
using a Leica confocal microscope and a Plan-Neoﬂuar
HCX 40.0 /1.25 oil UV objective and acquired using
IAS AF Lite software (Leica Microsystems). Images
were saved as TIFF ﬁles, and Photoshop (Adobe) and
PowerPoint (Microsoft) were used for composing the
panels.
RESULTS
Genotoxic stress induces changes in the subcellular
localization of Sam68
Depletion of Sam68 renders PCa cells more susceptible to
apoptosis induced by genotoxic drugs (29). To further
investigate this protective function of Sam68, we moni-
tored the intracellular localization of the protein in
response to MTX, a drug used in treatment of
androgen-resistant PCa patients (36). Sam68 was diﬀusely
localized in the nucleoplasm of control cells, whereas
treatment with MTX for 2–24h induced profound
changes in the localization of the protein (Figure 1A and
B). After 2–4h, Sam68 accumulated in ring-shaped struc-
tures that surrounded the nucleoli, whereas at later times it
was enriched in large granules that were faintly stained by
DAPI (Figure 1A and B). Notably, treatment with MTX
caused morphological changes in PC3 cells, which at
phase contrast appeared more ﬂattened on the cul-
ture plate with larger nuclei than untreated cells
(Figure 1C). Western blot analysis showed that MTX
did not aﬀect Sam68 protein levels during the time-course-
of the treament (Figure 1D). Accumulation of Sam68
in nuclear granules was also observed in another PCa
cell line, LNCaP, and in HeLa cells (Supplementary
Figure S1), indicating that it is not a PC3 cell-speciﬁc
response. Moreover, similar changes in the subcellular
localization of Sam68 were also elicited by cisplatin
(Figure 1E), an alkylating agent that causes DNA
damage by a diﬀerent mechanism than MTX, suggesting
that various genotoxic stresses trigger this event in PCa
cells.
To test whether the Sam68-containing granules were
foci of DNA lesions induced by MTX, we co-stained
PC3 cells with Sam68 and the phosphorylated form of
H2AX (gH2AX), a substrate of the ATM kinase that
marks foci of double-strand breaks (37). However,
confocal microscopy analysis showed that Sam68
nuclear granules and double-strand breaks foci are dif-
ferent structures (Supplementary Figure S2A). Other
nuclear structures aﬀected by genotoxic stress are the
promyelocytic leukemia (PML) nuclear bodies, which
are sites of post-transcriptional modiﬁcations of nuclear
proteins such as HIPK2 and p53 (38). PML bodies are
dynamic compartments that act as DNA damage
sensors, they are regulated by ATM and its target Chk2,
and their number in the cell increases under genotoxic
stress (39). Nevertheless, also in this case confocal micros-
copy demonstrated that MTX-inducedSam68 nuclear
granules and PML bodies are diﬀerent entities
(Supplementary Figure S2B).
Sam68 colocalizes with other stress-responsive RBPs both
in nuclear and cytoplasmic granules
In addition to the nuclear relocalization of Sam68, 16–24h
of treatment with MTX (Figure 1F) and cisplatin (data
not shown) caused the translocation of Sam68 in the cyto-
plasm in  5–10% of cells, where it accumulated in
cytoplasmic granules. These structures resembled the
cytoplasmic stress granules (SGs) in which splicing
factors, such as hnRNP A1 and TIA-1, re-localize as a
stress-adaptation response of the cell (40). Thus, we
tested whether genotoxic stress caused recruitment of
Sam68 to the same granules marked by these
stress-response RBPs. Confocal immunoﬂuorescence
analyses showed that MTX-induced genotoxic stress
caused subcellular re-distribution of both hnRNP A1
and TIA-1 in the nucleus and in the cytoplasm similar
to that observed for Sam68 (Figure 2).Moreover, Sam68
colocalized, with identical time-course, to the same struc-
tures as hnRNP A1 and TIA-1 both in the nucleus
(Figure 2A and B, and Supplementary Figure S3A) and,
albeit only in a small percentage of cells, in the cytoplasm
(Supplementary Figure S3B and C).
Colocalization of Sam68 with TIA-1 in cytoplasmic
stress granules has been recently reported in cells under
oxidative stress (41). However, no colocalization of these
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circumstances, suggesting that these structures are specif-
ically induced by genotoxic stress. Nuclear stress bodies
(nSBs) where RBPs are actively recruited have been
previously described in response to heat shock.
However, although these structures contained Sam68,
SAFB and the SR protein ASF/SF2, other RBPs
involved in splicing like hnRNP A1 or the SR protein
SC35 were not recruited (20). To further characterize the
nature of the MTX-induced stress granules, we analysed
the subcellular localization of SC35 and ASF/SF2 in
response to this genotoxic drug in PC3 cells. Confocal
microscopy showed that SC35 and ASF/SF2 localized
both to nuclear speckles and in the nucleoplasm in
untreated cells, whereas MTX caused their accumulation
in large granules in a time-dependent manner. Notably,
Sam68, which is mostly diﬀused in the nucleoplasm of
untreated PC3 cells, colocalized with these SR proteins
in the large nuclear granules only after 8–24h of MTX
treatment (Figure 3A and B). These results indicate that
MTX-induced nuclear stress granules are novel structures
where both hnRNPs and SR proteins accumulate together
with Sam68.
The GSG domain of Sam68 is suﬃcient for relocalization
after genotoxic stress
We have previously demonstrated that Sam68 interacts
with hnRNP A1 in a functional splicing complex (28).
This interaction required the C-terminal 93 residues of
Sam68, downstream of the GSG domain that mediates
homodimerization and RNA binding. Similarly, it was
recently shown that the region comprised by residues
269–321, mostly outside of the GSG, was required for
the interaction with TIA-1 and the recruitment of Sam68
to cytoplasmic SGs (41). Since Sam68 colocalized with
hnRNP A1 and TIA-1 in MTX-induced nuclear
granules, we set out to test whether its relocalization
required the interaction with these RBPs. PC3 cells were
transiently transfected with full-length GFP-Sam68 or
with GFP-Sam68GSG (residues 91–276), which lacks the
regions required for the interaction with hnRNP A1 and
TIA-1. We observed that full-length GFP-Sam68 behaved
like the endogenous protein and relocalized into nuclear
granules after MTX-induced stress (Figure 4A). The
GFP-Sam68GSG protein showed a diﬀused localization
both in the cytoplasm and in the nucleus in untreated
cells. However, this deletion mutant lacking most of the
Figure 1. Sam68 relocalizes in subcellular compartments after genotoxic stress. (A) Time course treatment of PC3 cells with 5mM MTX. Treated
cells were stained with an anti-Sam68-speciﬁc antibody and analysed by immunoﬂuorescence by confocal microscopy. The localization of Sam68
around the nucleoli (2h MTX) andin large nuclear granules (8–24h MTX) is indicated by white arrows. Scale bar=15mm. (B) Graph ofthe
percentage of PC3 cells treated showing ring-shaped structures and granules after MTX treatment (5mM, 2–24h). (C) Phase contrast images of
control and MTX-treated cells (5mM). (D) Cell extracts (10mg) from PC3 treated as in panel A were analysed by SDS–PAGE and western blot with
the indicated antibodies. (E) PC3 cells were treated for 16h with 80mM cisplatin, ﬁxed and stained with anti-Sam68 antibody. The white arrow
indicates a Sam68 granule in treated cells. Scale bar=15mm. (F) Confocal images of PC3 cells after prolonged treatment (24h) with 5mM MTX
indicating the translocation of Sam68 in the cytoplasm. Scale bar=15mm.
Nucleic Acids Research,2010, Vol.38, No. 9 3009Figure 2. Sam68 colocalizes with stress-response RNA-binding proteins after genotoxic stress. PC3 cells were treated with 5mM MTX (2–24h) and
co-stained with Sam68 and hnRNP A1 (A) or TIA-1 (B) speciﬁc antibodies and analysed by confocal microscopy as in Figure 1. The merge panels
show colocalization of Sam68 and hnRNP A1 or TIA-1 to the same nuclear granules. Scale bar=10mm.
Figure 3. SR proteins colocalize with Sam68 in nuclear granules after genotoxic stress. Confocal analyses of PC3 cells treated with 5mM MTX
(2–24h) and co-stained with Sam68 and SC35 (A) or ASF/SF2 (B). Sam68 colocalized to the same stress-induced nuclear granules as SC35 and ASF/
SF2 after 8–24h of MTX treatment. Stress-induced nuclear granules are pointed by white arrows. Scale bar=10mm.
3010 Nucleic Acids Research, 2010,Vol.38, No. 9regions required for protein–protein interactions and
post-translational modiﬁcations (21) was still capable to
relocalize into nuclear granules after MTX treatment
(Figure 4B), indicating that the homodimerization and
RNA-binding activity of Sam68 were suﬃcient for this
event. On the other hand, depletion of Sam68 by RNAi
in PC3 cells did not aﬀect the recruitment of hnRNP A1
and TIA-1 to the nuclear granules after MTX treatment
(data not shown), indicating that these RBPs are
independently recruited to these structures during
genotoxic stress.
Signal transduction pathways activated after genotoxic
stress in PCa cells do not aﬀect Sam68 accumulation in
nuclear granules
Sam68 is known to link signal transduction pathways to
RNA metabolism (21). We asked whether the
MTX-induced subcellular relocalization of Sam68 was
determined by activation of speciﬁc signal transduction
pathways. PC3 cells were treated with MTX in a time-
and dose-dependent manner and extracts were analysed
by western blot. The DNA-damage response involves acti-
vation of the ATM/Chk2 signal transduction pathway
(42), which recruits DNA repair proteins to the lesions,
and of mitogen activated protein kinases (MAPKs)
responsive to various stresses, such as JNK1/2 and p38
(43,44). We observed that MTX induced phosphorylation
of the ATM substrate Chk2 at both doses, whereas full
activation ofJNK1/2 and p38 required the higher dose
(Supplementary Figure S4A). Both doses of MTX were
suﬃcient to elicit growth arrest, albeit at diﬀerent cell
cycle phases (Supplementary Figure S5), and to aﬀect
the localization of Sam68 in the nucleus. However, we
observed that 0.5mM MTX, which was suﬃcient
only for complete activation ofthe ATM/Chk2
(Supplementary Figure S4A), caused relocalization of
Sam68 to the ring-shaped structures surrounding the
nucleoli, typical of the early phase of the response to
higher MTX doses. On the other hand, the accumulation
of Sam68 in the nuclear granules was induced only by the
higher dose of MTX (5mM) (Supplementary Figure S4B)
and correlated more with the activation of MAPKs
(Supplementary Figure S4A). Nevertheless, we tested
whether any of these signal transduction pathways was
required for Sam68 accumulation in nuclear granules.
Cells were treated with inhibitors of ATM (ATM-inh.),
the p38 downstream kinase MNK1 (MNK-inh.), which
is known to regulate hnRNPA1 nucleocytoplasmic
export after stresses (18), p38 (SB202190) andJNK1/2
(JNK-inh.). Remarkably, none of the inhibitors tested
suppressed relocalization of Sam68 to nuclear granules
induced by 5mM MTX (Supplementary Figure S6A and
B). Western blot analysis conﬁrmed the inhibitory eﬀects
of these drugs on the corresponding signal transduction
pathways, Chk2 phosphorylation for the ATM-inh.
(Supplementary Figure S6C), eIF4E phosphorylation for
MNK-inh. and SB202190 (Supplementary Figure S6D
and E), and c-Jun mobility shift for the JNK-inh.
(Supplementary Figure S6E). Moreover, MTX treatment
did not aﬀect the levels of serine/threonine or tyrosine
phosphorylation of Sam68 immunoprecipitated from
PC3 cells (data not shown). These results indicate that
post-translational modiﬁcations by stress-induced signal
transduction pathways are not required for
MTX-induced relocalization of Sam68 in nuclear stress
granules.
Sam68 nuclear granules induced by genotoxic stress are
transcriptionally active foci
It has been recently shown that heat shock induced the
transcriptional activation of tandem arrays of repetitive
Satellite III (SatIII) sequences, resulting in expression of
non-coding RNA molecules of various length (45,46).
SatIII RNAs remain associated with sites of transcription
(47) and are bound by several RBPs, like SAFB and ASF/
SF2, thus leading to the formation of nSBs (20). A milder
induction of SatIII RNA transcription was also observed
with other stresses, including that elicited by etoposide
(30), a topoisomerase II inhibitors like MTX. However,
we observed that, unlike heat shock (Supplementary
Figure S7A), MTX did not stimulate transcription of
SatIII RNAs in PC3 cells (Supplementary Figure S7B
Figure 4. The Sam68 GSG homodimerization and RNA-binding
domain is suﬃcient for relocalization after genotoxic stress. PC3
cellswere transiently transfected with full-length GFP-Sam68 (A)o r
with GFP-Sam68GSG (B) and treated with 5mM MTX. After 24h,
the cells were ﬁxed and analysed by confocal microscope. Scale
bar=10mm.
Nucleic Acids Research,2010, Vol.38, No. 9 3011and C), suggesting that MTX-induced nuclear granules
were diﬀerent structures than heat shock-induced nSBs.
Next, we hypothesized that MTX induced the
recruitment of Sam68 to speciﬁc domains of chromatin
structure and/or function. To test this possibility, we
separated chromatin components using micrococcal
nuclease treatment followed by divalent ions and EDTA
extractions as previously described (33,34). This procedure
yields fractions enriched (S1) or depleted (S2) in
transcriptionally active genes, which also remain
associated to the insoluble chromatin and nuclear matrix
(P) (34). Chromatin separation from control or treated
PC3 cells showed that MTX caused an enrichment of
Sam68 and hnRNP A1 in the S1 fraction at both doses,
similarly to what observed for the transcription factor
TFIIH p89 (Figure 5A and B). The eﬀect of MTX
appeared speciﬁc because it did not aﬀect localization of
Lamin B in the nuclear matrix fraction P (Figure 5A). This
experiment suggested that genotoxic stress induces a
change in distribution of chromatin components, with
an enrichment of the splicing factors Sam68 and hnRNP
A1 in the transcriptionally active fractions.
Since many splicing factors are recruited to the
transcriptionally active chromatin by phosphorylated
RNAPII, we investigated its localization in response to
MTX treatment. We performed a time course treatment
with MTX and stained PC3 cells with a RNAPII antibody
(H5). This antibody is speciﬁc for the phosphorylated
serine2 in the carboxyterminal domain (CTD), which
marks the elongating form of RNAPII engaged in tran-
scription (48). We observed that genotoxic stress changed
the subcellular distribution ofRNAPII from a widely
diﬀused localization in the nucleoplasm to discrete
nuclear granules (Figure 6A). Moreover, co-staining of
cells with H5 and Sam68 antibodies clearly showed that
the two proteins colocalized to the same nuclear granules
induced by MTX treatment (Figure 6B).
Although the hyperphosphorylated elongating form of
RNAPII generally localizes into transcriptionally active
foci throughout the nucleoplasm, it was previously
shown that it can redistribute into transcriptionally
inactive speckles under a general block of transcription
induced by a-amanitin or heat shock (49). Thus, to test
whether these stress-induced nuclear granules were still
transcriptionally active, we performed a bromo-uridine
(BrU) incorporation assay to follow RNA synthesis
in situ. PC3 cells were treated with MTX for increasing
times and incubated with BrU in the last hour of treat-
ment. A time-course experiment indicated that 60min of
labelling with BrU were necessary to readily detect de novo
transcription by immunoﬂuorescence in PC3 cells
(Figure S8A). Confocal analysis revealed that BrU
Figure 5. Genotoxic stress induced by MTX causes an enrichment of the splicing factors Sam68 and hnRNP A1 in the transcriptionally active
fractions. (A) Western blot analysis of chromatin fractions obtained from PC3 cells treated with 0.5 or 5mM MTX. Distribution of proteins in total
digested nuclei (T) and in chromatin fractions (supernatants S1–S2 and pellet, P) was analysed with the indicated antibodies. Lamin-B was usedas
nuclear matrix marker. Staining for histone H3 was performed as loading control. (B and C) Densitometric analysis of the distribution of Sam68 (B)
and TFIIH p89 (C) in S1–S2–P chromatin fractions from three experiments is expressed as percentage of the levels of these proteins in the total
digested nuclei (T) (mean±SD; *P<0.05; **P<0.01).
3012 Nucleic Acids Research, 2010,Vol.38, No. 9staining, which was at ﬁrst diﬀused into the nucleoplasm
and partly in the cytoplasm, accumulated into speciﬁc
nuclear foci under genotoxic stress (Supplementary
Figure S8B). To understand if these foci were the same
stress-induced sites of Sam68 accumulation, MTX-treated
PC3 cells were stained for both BrU and Sam68. As
clearly shown in Figure 7A, the stress-induced Sam68
nuclear granules incorporated BrU, indicating that they
are transcriptionally active foci.
Genotoxic stress induced by MTX aﬀects CD44 AS
proﬁle in a Sam68-dependent manner
Since we observed that Sam68 is recruited from the
nucleoplasm to foci of residual transcription under
genotoxic stress, we asked whether its function aﬀects
MTX-modulated AS of target mRNAs. A well described
splicing event regulated by Sam68 is the inclusion of the
variable v5 exon in CD44 (26,27,50), a membrane receptor
involved in cell proliferation and migration (51). The
CD44 gene contains 10 constitutive and variable exons
that can be diﬀerentially assembled in the mature
mRNA (52). Inclusion of several variable exons (v5, v6,
v8 and v10) correlates with increased cell motility,
invasion of neighboring tissues and malignancy and it
has been correlated to poor prognosis in patients
(50–53). Moreover, recent data have implicated a change
in CD44 splicing isoforms as an adaptive response of some
cancer cells to genotoxic stress (12). Thus, we investigated
whether MTX caused Sam68-dependent modulation of
the CD44 v5 exon inclusion. Control PC3 cells (pLKO),
or PC3 cells depleted of Sam68 by stable transfection of a
siRNA (pLKO si-Sam68), were treated for 2h with 0.5 or
5mM MTX. Cells were then allowed to recover after
damage and harvested after 24h (3). Under these condi-
tions, Sam68 and BrU labelling accumulated in nuclear
stress granules like under continuous MTX treatment
(Figure 7B), and cells underwent a similar proliferation
arrest (Supplementary Figure S5E and F). This protocol
was used to allow cells to recover, thereby allowing higher
transfection eﬃciency and transcription of new mRNAs
without the interference of MTX, a genotoxic agent that
could damage the transfected minigene. Real-time PCR
analysis of CD44v5 endogenous levels, with respect to
the constitutive exons c6 and c7, showed that MTX
induced an increase in v5 inclusion in control PC3 cells
(Figure 8A). Importantly, this eﬀect required Sam68
expression, because its down-regulation by RNAi
completely suppressed the eﬀect of MTX (Figure 8A
and B). In order to understand if the increase of
CD44v5 isoform levels was directly due to AS modulation,
we used a splice-reporter minigene in which inclusion of
exon v5 leads to expression of ﬁreﬂy luciferase (pETv5luc)
(26,31). pLKOand pLKO si-Sam68 PC3 cells were treated
for 2h with 5mM MTX. After recovery from the stress,
cells were then transiently transfected with the
splice-reporter minigene and analysed for luciferase
activity 24h later. Remarkably, also in this case, we
observed that MTX treatment stimulated the inclusion
of the variable CD44 exon v5 in a Sam68-dependent
manner (Figure 8C). Moreover, inclusion of exon v5 in
Figure 6. RNAPII and Sam68 colocalize in genotoxic stress-induced nuclear granules. (A) PC3 cells untreated (control) or treated with 5mM MTX
(2–24h), were stained with a RNAPII antibody (H5) speciﬁc for the phosphorylated serine2 and analysed by confocal microscopy. (B) Co-staining of
Sam68 and phosphorylated RNAPII (H5) in PC3 cells treated as in panel A. Scale bar=10mm.
Nucleic Acids Research,2010, Vol.38, No. 9 3013Sam68-depleted cells could be restored by overexpression
of a non-degradable form of Sam68 (murine mycSam68 in
Figure 8C and D). Myc-Sam68 similarly induced v5 inclu-
sion also in pLKO control cells (data not shown), as
previously shown for parental PC3 cells (29). Western
blot analysis of cell extracts conﬁrmed down-regulation
of Sam68 levels in the pLKO si-Sam68 PC3 cells used
for both experiments described above and the recovery
in expression after transfection of the murine mycSam68
(Figure 8B and D).
DISCUSSION
In this report, we have investigated the subcellular local-
ization and the function of Sam68 during the
MTX-induced DNA damage response of PCa cells.
These studies stemmed from our previous observation
that Sam68 played a protective role in PCa cells subjected
to genotoxic stress induced by chemotherapeutic drugs
(29). We now show that genotoxic stress stimulates the
accumulation of Sam68 in nuclear granules, together
with other splicing regulators like TIA-1, SR proteins
and hnRNP A1. Moreover, we provide evidence that
these MTX-induced granules are transcriptionally active
and contain the phosphorylated form of RNAPII. Finally,
our results indicate that the subnuclear relocalization of
Sam68 correlates with changes in AS of its mRNA target
CD44 and that Sam68 function is necessary for such AS
modulation. Thus, our study identiﬁes Sam68 as a novel
stress-regulated RBP involved in the response to genotoxic
stress in PCa cells.
As a ﬁrst approach, we attempted a characterization of
the Sam68 nuclear granules induced by MTX using
markers of previously described nuclear structures
aﬀected by genotoxic stress. Topoisomerase inhibitors
and alkylating agents cause double-strand breaks in the
DNA, which set in motion a well-characterized DNA
damage response (1,42). The ATM kinase is recruited to
the lesions and phosphorylates H2AX, which acts as a
signal to recruit proteins involved in DNA repair. Thus,
the phosphorylated form of this histone (gH2AX) is used
as a marker of DNA repair foci. By using this marker, we
were able to show that Sam68 is not recruited to
double-strand break foci in the cell. By using a similar
approach, we also demonstrated that Sam68 nuclear
granules were diﬀerent from the PML bodies, which also
enlarge after DNA damage and participate to the
genotoxic stress response (39). Moreover, inhibition of
the ATM signalling pathway did not aﬀect recruitment
of Sam68 to the nuclear foci. Thus, although Sam68
relocalization is induced by lesions in the DNA, the sites
of its accumulation are not chromatin foci involved in
DNA repair.
The most characterized nuclear structures induced by
stress are the nSBs that form in cells exposed to heat
shock (20). These bodies present several features in
common with the MTX-induced nuclear granules. First,
both structures are characterized by accumulation of
Sam68 (19 and this work). Moreover, nSBs also recruit
Figure 7. Sam68 nuclear granules induced by genotoxic stress are transcriptionally active foci. (A) BrU-incorporation assay in PC3 cells untreated
(control) ortreated with 5mM MTX (2–24h). PC3 cells were stained with anti-Sam68 and BrU speciﬁc antibodies. Confocal analysis revealed that
Sam68 MTX-induced nuclear granules incorporate BrU. (B). PC3 cells were treated for 2h with 5mM MTX, and allowed to recover 24h after
damage. At the end of incubation, cells were ﬁxed and stained with anti-Sam68 and BrU speciﬁc antibodies. Scale bar=10mm.
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stress granules induced by MTX. However, the activity
of these structures appears somewhat diﬀerent, because
nSBs are engaged in transcription of SatIII repetitive
sequences after heat shock (46), whereas these non-coding
RNAs are not transcribed in response to MTX treatment.
Moreover, the repertoire of RBPs recruited to nSBs and
MTX-induced nuclear granules is only partially
overlapping. For instance, the latter structures recruit
also hnRNP A1 and SC35, which were excluded from
nSBs (20). Thus, although they share some components
and activities, they likely play diﬀerent functions in the
cell, which might be instructed by the diﬀerential needs
imposed by heat shock and DNA lesions.
Another type of RNA-containing structure that
resembles MTX-induced stress granules are the
well-characterized cytoplasmic SGs (40). SGs are
involved in the stress-adaptation response of the cell
induced by several poisoning treatments, such as oxidative
stress, osmotic and heat shock. Cytoplasmic SGs are
characterized by accumulation of the splicing regulators
TIA-1 and hnRNP A1. We observed that Sam68 also
accumulated in cytoplasmic granules in a subset of
MTX-treated cells. Since these structures also contained
hnRNP A1 and TIA-1, they can be regarded as bona-ﬁde
SGs. However, although Sam68 interacts with hnRNP A1
through its C-terminal region, a GFP-Sam68GSG deletion
mutant lacking the entire C-terminal domain was still
capable to relocalize both in the nuclear and cytoplasmic
stress granules after MTX treatment, suggesting that
interaction with hnRNP A1 was not necessary for these
events. Interestingly, our results are in line with the
recently described accumulation of Sam68 in cytoplasmic
SGs after oxidative stress (41), and suggest that genotoxic
stress also causes formation of Sam68-containing
SGs. These data indicate that Sam68 is part of a
Figure 8. Genotoxic stress induced by MTX aﬀects CD44 alternative splicing in a Sam68-dependent manner. (A) control pLKO and
pLKO-si-Sam68 PC3 cells were treated for 2h with 0.5 (white columns) or 5mM MTX (dim grey columns), allowed to recover from stress for
24h and analysed for the levels ofendogenous CD44 v5 exon inclusion by real-time PCR. CD44 v5 levels in untreated cells (dark grey columns) were
set as 1 and MTX-induced v5 inclusion was calculated as fold increase. Samples were normalized for CD44 constitutive isoforms levels (see details
under ‘Materials and Methods’ section). Data are expressed as mean-fold induction ±SD from three separate experiments. (B) Western blot analysis
of cellextracts (15mg) from the PC3 clones conﬁrmed down-regulation of Sam68 levels in pLKO-si-Sam68 cells. (C) pLKO and pLKO-si-Sam68 PC3
cells were treated with 5mM MTX for 2h, allowed to recover and transiently transfected with pETv5Luc minigene in the presence (+) or absence ( )
of murine mycSam68. The v5-Luc activity in untreated cells was set as 100% (dark grey columns) and v5-Luc activity in MTX-treated cells without
(dim grey columns) or with (white column) murine mycSam68 was expressed as percentage respect to untreated cells.Data are expressed as mean-fold
induction ±SD from three separate experiments. (D) Western blot analysis of the pLKO clones cellextracts 15mg) conﬁrmed down-regulation
of Sam68 levels in pLKO-si-Sam68 cells and the overexpression of mycSam68. Protein loading was normalized on hnRNP A1 levels both in
panel B an D.
Nucleic Acids Research,2010, Vol.38, No. 9 3015RNA-mediated genotoxic stress response of the cell and
that it may exert an active role through changes in its
subcellular localization.
Sam68 is a prototype of the STAR proteins, which are
known to link signal transduction pathways to changes in
RNA metabolism (21). For instance, growth factors stim-
ulate the MAPKs ERK1/2, which in turn phosphorylate
Sam68 and stimulate its splicing activity (26). Since MTX
triggered the activation of stress-response MAPKs, we
asked whether these pathways were involved in Sam68
relocalization. However, our results, obtained with
speciﬁc inhibitors of the p38 and JNK1/2 pathways,
strongly suggest that phosphorylation of Sam68 by these
kinases is not required for its recruitment to
MTX-induced nuclear stress granules.
Chromatin fractionation experiments and
colocalization with the phosphorylated RNAPII and
nascent RNAs indicated that MTX-induced nuclear
granules were transcriptionally active. We labelled the
cells in the last hour of treatment, thus, the BrU-positive
granules are likely sites of de novo synthesis of RNA rather
than sites of accumulation of RNAs that had been
synthesized before the MTX treatment. Since several
RBPs involved in AS and other steps of post-
transcriptional regulation of mRNAs were recruited to
these MTX-induced nuclear granules, we asked whether
Sam68 was involved in processing of target mRNAs
during the genotoxic stress. A particularly interesting
splicing target of Sam68 is CD44. This gene encodes for
several isoforms that diﬀer for the inclusion of variable
exons (v1–v10), which confer oncogenic potential to the
corresponding proteins (51–53). Remarkably, a recent
study showed that CD44 undergoes profound changes in
AS during genotoxic stress caused by cisplatin in cancer
cells (12). Thus, we tested whether MTX induced changes
in the inclusion of v5, the target of Sam68 activity (26),
and whether or not these changes required Sam68.
Remarkably, our experiments, which monitored both the
endogenous CD44 mRNA and a reporter minigene,
clearly showed that v5 exon inclusion correlated with for-
mation of the nuclear stress granules and that this splicing
event was dependent on Sam68 expression. Thus, it is
possible that compartmentalization of Sam68, and of
other splicing factors, in the transcriptionally active
nuclear stress granules redirects the splicing machinery
during the response to genotoxic stress, thereby aﬀecting
speciﬁc splicing events. This response might allow the cell
to produce protein isoforms that allow to withstand the
stress and to favor repair of the damage caused. Indeed,
expression of CD44v5 isoforms was shown to have prog-
nostic value in human thymic tumors (53). In this regard,
it will be interesting to determine the genes aﬀected by
MTX at the level of AS on a large scale, similarly to
what recently described for the response to UV irradiation
(3). Since Sam68 protects PCa cells from genotoxic stress
(29), it is possible that its splicing targets contribute to
enhance cell survival in response to DNA damage. Thus,
future studies will aim at clarifying how Sam68 modulates
AS in response to genotoxic stress and at the identiﬁcation
of mRNAs whose AS is regulated in a Sam68-dependent
manner after DNA damage in cancer cells.
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